[Observation of low-dose HA/HAA regimen as induction chemotherapy on elderly patients with acute myeloid leukemia]

Zhonghua Xue Ye Xue Za Zhi. 2014 Mar;35(3):256-9. doi: 10.3760/cma.j.issn.0253-2727.2014.03.020.

[Article in Chinese]

Authors

Dijiong Wu¹, Baodong Ye¹, Jianping Shen¹, Yiping Shen¹, Shengyun Lin¹, Zhiping Hu¹, Qinghong Yu¹, Zhiyin Zheng¹, Laijun Peng¹, Shan Liu¹, Conghua Ji¹, Yunfei Luo¹, Xiaowen Wen¹, Keding Shao¹, Yu Zhang¹, Yanting Gao¹, Dan Chen¹, Yuhong Zhou¹

Affiliation

¹ Zhejiang Provincial Hospital of TCM, Department of Hematology, Hangzhou 310006, China.

PMID: 24666499
DOI: 10.3760/cma.j.issn.0253-2727.2014.03.020

No abstract available

Publication types

Observational Study
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Cytarabine / administration & dosage*
Cytarabine / therapeutic use
Female
Harringtonines / administration & dosage*
Harringtonines / therapeutic use
Humans
Induction Chemotherapy / methods*
Leukemia, Myeloid, Acute / drug therapy*
Male
Middle Aged

Substances

Harringtonines
Cytarabine